Current and Emerging Therapies for Ocular Herpes Simplex Virus Type-1 Infections

被引：57
|
作者：
Koganti, Raghuram [1 ]
Yadavalli, Tejabhiram [1 ]
Shukla, Deepak [1 ,2 ]
机构：
[1] Univ Illinois, Dept Ophthalmol & Visual Sci, 1855 W Taylor St, Chicago, IL 60612 USA
[2] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA
来源：
MICROORGANISMS | 2019年 / 7卷 / 10期
基金：
美国国家卫生研究院;
关键词：
herpes simplex virus; herpesvirus; keratitis; ocular therapy; antiviral; acyclovir; HEPARAN-SULFATE; DRUG-RESISTANCE; EYE DISEASE; CELL-FUSION; VIRAL ENTRY; ACYCLOVIR; PROTEIN; PEPTIDE; REPLICATION; KERATITIS;
D O I：
10.3390/microorganisms7100429
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Herpes simplex virus type-1 (HSV-1) is a neurotropic, double-stranded DNA virus that can cause a wide variety of diseases, including many ocular pathologies. It is one of the leading causes of infectious blindness in the United States. Because of its ubiquitous nature and its potential to cause serious ocular maladies, there is a significant need for more effective antiviral therapies against ocular HSV-1. In this review, we discuss the lifecycle of HSV-1 as it pertains to corneal infections and the clinically approved as well as emerging treatments to combat HSV-1 infections. We also highlight some newly identified host targets for the antiviral drug development.
引用
收藏
页数：16
相关论文
共 50 条
  • [1] Nanoparticles: A Promising Treatment for Herpes Simplex Virus Type-1 Infections
    Ahmadi, Mahsa
    Bolourchi, Negin
    Rezaei, Zeinab
    Badmasti, Farzad
    Shafiei, Morvarid
    MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS, 2021, 10
  • [2] Ocular manifestations of herpes simplex virus
    Valerio, Gabriel S.
    Lin, Charles C.
    CURRENT OPINION IN OPHTHALMOLOGY, 2019, 30 (06) : 525 - 531
  • [3] Evaluating the therapeutic efficacy of triptolide and (S)-10-hydroxycamptothecin on cutaneous and ocular Herpes Simplex Virus type-1 infections in mice
    Aliabadi, Nasrin
    Jamalidoust, Marzieh
    Pouladfar, Gholamreza
    Azarpira, Negar
    Ziyaeyan, Atoosa
    Ziyaeyan, Mazyar
    HELIYON, 2022, 8 (08)
  • [4] Manzamine A as a Novel Inhibitor of Herpes Simplex Virus Type-1 Replication in Cultured Corneal Cells
    Palem, Jayavardhana R.
    Bedadala, Gautam R.
    El Sayed, Khalid A.
    Hsia, Shao-chung V.
    PLANTA MEDICA, 2011, 77 (01) : 46 - 51
  • [5] An Investigative Peptide-Acyclovir Combination to Control Herpes Simplex Virus Type 1 Ocular Infection
    Park, Paul J.
    Antoine, Thessicar E.
    Farooq, Asim V.
    Valyi-Nagy, Tibor
    Shukla, Deepak
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (09) : 6373 - 6381
  • [6] Herpes simplex virus genital infections: Current concepts
    Gardella C.
    Current Infectious Disease Reports, 2011, 13 (6) : 588 - 594
  • [7] Treatment of herpes simplex virus infections
    Snoeck, R
    De Clercq, E
    INFECTIONS IN MEDICINE, 1999, 16 (04) : 249 - +
  • [8] Current and future therapies for herpes simplex virus infections: mechanism of action and drug resistance
    James, Scott H.
    Prichard, Mark N.
    CURRENT OPINION IN VIROLOGY, 2014, 8 : 54 - 61
  • [9] The effects of interferon-α and acyclovir on herpes simplex virus type-1 ribonucleotide reductase
    O'Brien, WJ
    Narasimhan, J
    Guy, J
    Tom, P
    Taylor, JL
    ANTIVIRAL RESEARCH, 1998, 38 (02) : 107 - 116
  • [10] Herpes simplex virus infections of the newborn
    Kimberlin, David W.
    SEMINARS IN PERINATOLOGY, 2007, 31 (01) : 19 - 25
12345